about
The global threat of Zika virus to pregnancy: epidemiology, clinical perspectives, mechanisms, and impactIdentification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral EntryExpression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 BindingIdentification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing AntibodiesAllosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivityClaudin association with CD81 defines hepatitis C virus entry.Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigsThe SR-BI partner PDZK1 facilitates hepatitis C virus entry.Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry.Longitudinal Sequence and Functional Evolution within Glycoprotein E2 in Hepatitis C Virus Genotype 3a InfectionThe role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments.Role for the terminal clasp of HIV-1 gp41 glycoprotein in the initiation of membrane fusionHepatitis C virus nonstructural protein 5B is involved in virus morphogenesis.Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable RegionIn silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface.Forced virus evolution reveals functional crosstalk between the disulfide bonded region and membrane proximal ectodomain region of HIV-1 gp41Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus.HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users.Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies.Characterization of glycoprotein B of the gammaherpesvirus equine herpesvirus-2.An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.Calsyntenin-1 mediates hepatitis C virus replication.Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line.Functional evolution of the HIV-1 envelope glycoprotein 120 association site of glycoprotein 41.Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function.Sequence conservation and antigenic variation of the structural proteins of equine rhinitis A virus.The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity.Identification of noncytopathic equine rhinovirus 1 as a cause of acute febrile respiratory disease in horsesHigh incidence of hepatitis C virus reinfection in a cohort of injecting drug users.Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion.A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virus.Transient and stable expression of the HCV envelope glycoproteins in cell lines and primary hepatocytes transduced with a recombinant baculovirus.Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2.Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins.Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry.
P50
Q26247068-B0E5D904-828C-4655-9B58-A6EA2551178CQ27472909-12EBFF7D-5F65-4227-9896-0362777300F9Q27477463-8F1FABFD-A25C-4DDB-AC5D-149880745069Q27481026-1ADAA5D8-0961-4301-B88A-C7F42A4A2554Q27487399-67F09D71-3062-45AB-9A90-1C35F6EEFB25Q28485983-28C3AC2D-C88F-4FE8-A972-209DB61DF089Q29465808-65937DAC-1DEB-40CD-B09A-74B537EAD619Q33273910-D2F038DA-BE78-4796-BC82-A41802D5CB56Q33612608-9B595221-EEA6-442F-8B4B-0487DF3557FFQ33719403-F3B1D2F2-BB83-4A40-82B3-07940EFC5E01Q35213305-6538A1D3-196E-4D34-A973-DD3B874DBDAFQ35630492-332620A9-68F2-4715-98BC-CEC5C905E1E9Q35750560-3244338C-DEB9-4132-B71D-E65A296AFF35Q35842116-9BC059EA-C029-44B2-A343-4C030ED7F530Q35943750-45B739F1-8966-4F5C-A4BA-5A80A89B79B9Q36334312-3DBB6954-804F-4165-886D-2E49334BA464Q36546942-A027A658-7860-49E9-9039-FD642171FA42Q36814871-CAE1CC82-ED49-4DCC-805C-8CDA269A859AQ36829395-92FE0B1A-5AD2-42E3-928F-3FAB1E4AACA5Q37129639-1C658133-31AB-4063-84DB-F61A9286DC9AQ37288631-A34BCE06-BD90-4C0D-B5C3-BD6F02237AC7Q37540482-AA783576-D89D-47D9-BDCC-FFF6AA595429Q38234934-6C7B1F78-99D9-4460-BFD5-7FB45D4B1DB6Q38335204-2BD88C6F-90F2-400D-AF50-822E7E4577DDQ38723923-F0B185BC-E695-4877-AFB5-49354CD2EB7AQ38768742-05A3AAA9-1617-4B6D-8284-5D06ED809082Q38773125-EEC53FA9-72C1-4614-9355-A7DD7B3F3ECBQ39365770-ED061DD7-7274-4CCB-9D1B-592DC9919013Q39406155-7870E893-451F-42DD-945A-AB4153550DD9Q39604868-2B4431CE-7D41-4A87-8712-EA4B4DD6451DQ39647552-DF5A7C43-76C4-4FF1-84BF-206FD0EC2CCDQ40013410-8761533B-9B46-4F28-9513-FB7CE805B404Q40037737-D0587257-A0B1-4C0E-B803-ECDB4C202BA8Q40099683-FA805557-A722-4D0B-9EEB-182EE7231E3FQ40127843-3DBB72F5-E5B2-4111-B11F-8C51C8D1B691Q40152553-EDBA543B-E900-4B88-A21B-E129A36953C3Q40223848-9A52A0AC-4018-4B8D-ADBC-1288024754CAQ40465898-51D2AA0C-F4AB-4ABA-8201-87C02816288CQ40555914-A193B9CC-60EF-4046-96D7-30C5D24E1BF8Q40557371-DAC3018E-5027-43F5-BE49-95AB9E91983B
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Heidi E Drummer
@ast
Heidi E Drummer
@en
Heidi E Drummer
@es
Heidi E Drummer
@nl
Heidi E Drummer
@sl
type
label
Heidi E Drummer
@ast
Heidi E Drummer
@en
Heidi E Drummer
@es
Heidi E Drummer
@nl
Heidi E Drummer
@sl
prefLabel
Heidi E Drummer
@ast
Heidi E Drummer
@en
Heidi E Drummer
@es
Heidi E Drummer
@nl
Heidi E Drummer
@sl
P244
P106
P108
P21
P214
158144647673333572733
P244
no2015121784
P31
P496
0000-0002-0042-6277
P734
P735
P7859
lccn-no2015121784